Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential-Reference-Cited by-同舟云学术

Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential

Published:2020-05 Issue: Volume:41 Page:100645
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Haddadi Mohammad-Hossein,Hajizadeh-Saffar Ensiyeh,Khosravi-Maharlooei Mohsen,Basiri Mohsen,Negahdari Babak,Baharvand Hossein

Funder

Department of Royan Institute

Royan Stem Cell Technology Company

Stem Cell Biology and Technology Department of Royan Institute, Tehran University of Medical Sciences

and Royan Stem Cell Technology Company

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference118 articles.

1. Chimeric antigen receptor T cells in refractory B-cell lymphomas;Schuster;N Engl J Med,2017

2. Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy;Spear;Cancer Immunol Immunother,2019

3. Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T-and B-cell responses;Kim;Blood.,2015

4. Chimeric antigen receptor–and TCR-modified T cells enter main street and wall street;Barrett;J Immunol,2015

5. CAR T cells for infection, autoimmunity and allotransplantation;Maldini;Nat Rev Immunol,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in CAR-based therapy for kidney disease;Frontiers in Immunology;2024-08-20

2. Current cell therapies for systemic lupus erythematosus;Stem Cells Translational Medicine;2024-06-26

3. Car T Cells in Solid Tumors: Overcoming Obstacles;International Journal of Molecular Sciences;2024-04-10

4. Engineering transcriptional regulation for cell-based therapies;SLAS Technology;2024-04

5. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04